Meio Medical is a Health Care startup founded in 2018. The company focuses on automatic cardiac navigation technology and has independently developed magnetic navigation stereotactic therapy technology. Their flagship product is the MEIO magnetic navigation stereo positioning and precise ablation system, comprising a magnetic navigation host, three-dimensional mapping ablation, a flexible magnetic catheter, and a magnetic navigation workstation. Recently, Meio Medical completed the Pre-A+ round of financing, with Zhenghong Fund leading the investment. Existing investors such as Shun'an Capital and others also participated in this round. The latest milestone was the Series A investment on 14 August 2023, with Shanghai Creation Investment being the investor. This positioning and ablation system is set to revolutionize the treatment of cardiac conditions, and with the strong backing of notable investors, Meio Medical is poised for significant growth in the coming years.
No recent news or press coverage available for Meio Medical.